We are monitoring the impact of COVID-19 on Europe Oxygen Therapy Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 3544
Share on
Share on

Europe Oxygen Therapy Market Research Report – Segmented By Product, Application, End User and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 3544
Pages: 145

Europe Oxygen Therapy Market Size (2020 to 2025)

The Oxygen Therapy Market size in Europe was worth USD 0.56 billion in 2020 and is estimated to be growing at a CAGR of 5.77% to reach USD 0.74 billion by 2025.

Oxygen Therapy devices are useful, especially for people suffering from severe COPD or cystic fibrosis who suffer from chronically low oxygen levels in their bodies. The advantages of oxygen therapy include increased mental stamina, aversion to heart failure, and an enhanced breathing pattern. The administration and supply of supplementary oxygen have turned into an indispensable part of the management of numerous diseases. Furthermore, oxygen therapy applies to numerous diseases, for example, asthma, respiratory distress syndrome, and obstructive sleep apnea. Long-term oxygen treatments in patients suffering from chronic lung disease are believed to enhance life length and quality.

In Europe, the prevalence of COPD varies markedly across countries. For example, the Ministère de la Santé et des Solidaritiés estimates that between 6% and 8% of the adult population in France suffers from COPD. Interestingly, the Netherlands displays a 2% prevalence rate as evaluated by the National Institute for Public Health and the Environment. Generally, these devices are used to treat patients who are no longer able to receive adequate oxygen volumes through the breathing of natural air and require higher concentrations of oxygen.

A significant increase is expected in the number of patients on oxygen therapy as the population ages. As members of the 50 to 75 age demographics, who were often smokers in their youth, develop emphysema and related conditions. It is estimated that over 85% of the patients on oxygen therapy are once smokers.

This research report on the European Oxygen Therapy Market has been segmented & sub-segmented into the following categories:

By Product Type:

  • Oxygen Source Equipment
    • Oxygen Concentrators   
      • Fixed Oxygen Concentrators
      • Portable Oxygen Concentrators
    • Liquid Oxygen Devices   
    • Oxygen Cylinders             
  • Oxygen Delivery Devices                  
    • Oxygen Masks   
    • Nasal Cannulas  
    • Venturi Masks   
    • Non-Rebreather Masks 
    • Bag Valve Masks               
    • Other Devices    

By Application:

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Pneumonia

By End-user:

  • Home Healthcare
  • Hospitals

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, Europe has the second-highest revenue in the oxygen therapy devices market and is expected to grow further in the coming years. Favorable government policies and initiatives such as the Europe Committee for Hyperbaric Medicine (ECHM) involved promoting awareness pertaining to the treatment and thereby promoting the growth of the oxygen therapy devices market.

Companies leading the EU Oxygen Therapy Market are Chart Industries Inc., Invacare Corporation, Becton, Dickinson and Company, Smiths Medical, Teleflex Incorporated, Inogen, Inc., DeVilbiss Healthcare, Essex Industries, Inc., Allied Healthcare Products Inc., and Respan Products Inc.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Oxygen Source Equipment                              

                                                5.1.2.1 Oxygen Concentrators   

                                                                5.1.2.1.1 Fixed Oxygen Concentrators

                                                                5.1.2.1.2 Portable Oxygen Concentrators

                                                5.1.2.2 Liquid Oxygen Devices   

                                                5.1.2.3 Oxygen Cylinders             

                                5.1.3 Oxygen Delivery Devices                  

                                                5.1.3.1 Oxygen Masks   

                                                5.1.3.2 Nasal Cannulas  

                                                5.1.3.3 Venturi Masks   

                                                5.1.3.4 Non-Rebreather Masks 

                                                5.1.3.5 Bag Valve Masks               

                                                5.1.3.6 Other Devices    

                                5.1.4  Y-o-Y Growth Analysis, By Product                              

                                5.1.5  Market Attractiveness Analysis, By Product                            

                                5.1.6  Market Share Analysis, By Product                              

                5.2 Portability                                   

                                5.2.1 Introduction                           

                                5.2.2 Stationary Oxygen Therapy Devices                             

                                5.2.3 Portable Oxygen Therapy Devices                

                                5.2.4 Y-o-Y Growth Analysis, By Portability                           

                                5.2.5 Market Attractiveness Analysis, By Portability                         

                                5.2.6 Market Share Analysis, By Portability                          

                5.3 Application                                 

                                5.3.1 Introduction                           

                                5.3.2 Chronic Obstructive Pulmonary Disease                     

                                5.3.3 Asthma, Obstructive Sleep Apnea                

                                5.3.4 Respiratory Distress Syndrome                      

                                5.3.5 Cystic Fibrosis                        

                                5.3.6 Pneumonia                             

                                5.3.7 Y-o-Y Growth Analysis, By Application                         

                                5.3.8  Market Attractiveness Analysis, By Application                      

                                5.3.9  Market Share Analysis, By Application                       

                5.4 End User                                      

                                5.4.1 Introduction                           

                                5.4.2 Home Care Settings                            

                                5.4.3 Hospitals                  

                                5.4.4 Ambulatory Surgical Centers & Physician Offices                    

                                5.4.5 Others                      

                                5.4.6 Y-o-Y Growth Analysis, By End User                             

                                5.4.7 Market Attractiveness Analysis, By End User                           

                                5.4.8 Market Share Analysis, By End User                             

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By Portability      

                                                6.1.3.4 By Application    

                                                6.1.3.5 By End User        

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By Portability      

                                                6.1.4.4 By Application    

                                                6.1.4.5 By End User        

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By Portability      

                                                6.1.5.4 By Application    

                                                6.1.5.5 By End User        

                6.2 U.K                                 

                6.3 Spain                                             

                6.4 Germany                                     

                6.5 Italy                                               

                6.6 France                                          

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Respironics Inc.                                         

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Teleflex Incorporated                                            

                8.3 AirSep Corporation                                 

                8.4 DeVilbiss Healthcare                                               

                8.5 ResMed Inc                                

                8.6 Fisher & Paykel Healthcare Limited                                  

                8.7 Invacare                                       

                8.8 Essex Industries Inc.                                               

                8.9 HERSILL S.L.                                

                8.10 Weinmann Emergency Medical Technology                                              

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Oxygen Therapy Market, By Product, From 2020 to 2025 (USD Million)
  2. Europe Oxygen Source Equipment Market, By Region, From 2020 to 2025 (USD Million)
  3. Europe Liquid Oxygen Devices Market, By Region, From 2020 to 2025 (USD Million)
  4. Europe Oxygen Cylinders Market, By Region, From 2020 to 2025 (USD Million)
  5. Europe PAP Market, By Region, From 2020 to 2025 (USD Million)
  6. Europe Nasal Cannula Market, By Region, From 2020 to 2025 (USD Million)
  7. Europe Venturi Mask Market, By Region, From 2020 to 2025 (USD Million)
  8. Europe Non-Rebreather Mask Market, By Region, From 2020 to 2025 (USD Million)
  9. Europe Bag Valve Market, By Region, From 2020 to 2025 (USD Million)
  10. Europe CPAP Market, By Region, From 2020 to 2025 (USD Million)
  11. Europe Oxygen Delivery Device Market, By Region, From 2020 to 2025 (USD Million)
  12. Europe Oxygen Therapy Market, By Application, From 2020 to 2025 (USD Million)
  13. Europe Chronic Obstructive Pulmonary Disease Market, By Region, From 2020 to 2025 (USD Million)
  14. Europe Asthma Market, By Region, From 2020 to 2025 (USD Million)
  15. Europe Obstructive Sleep Apnea Market, By Region, From 2020 to 2025 (USD Million)
  16. Europe Respiratory Distress Syndrome Market, By Region, From 2020 to 2025 (USD Million)
  17. Europe Cystic Fibrosis Market, By Region, From 2020 to 2025 (USD Million)
  18. Europe Pneumonia Market, By Region, From 2020 to 2025 (USD Million)
  19. Europe Oxygen Therapy Market, By End Use, From 2020 to 2025 (USD Million)
  20. Europe Home Healthcare Market, By Region, From 2020 to 2025 (USD Million)
  21. Europe Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  22. U.K. Oxygen Therapy Market, By Product, From 2020 to 2025 (USD Million)
  23. U.K. Oxygen Therapy Market, By Application, From 2020 to 2025 (USD Million)
  24. U.K. Oxygen Therapy Market, By End Use, From 2020 to 2025 (USD Million)
  25. Germany Oxygen Therapy Market, By Product, From 2020 to 2025 (USD Million)
  26. Germany Oxygen Therapy Market, By Application, From 2020 to 2025 (USD Million)
  27. Germany Oxygen Therapy Market, By End Use, From 2020 to 2025 (USD Million)
  28. France Oxygen Therapy Market, By Product, From 2020 to 2025 (USD Million)
  29. France Oxygen Therapy Market, By Application, From 2020 to 2025 (USD Million)
  30. France Oxygen Therapy Market, By End Use, From 2020 to 2025 (USD Million)
  31. Italy Oxygen Therapy Market, By Product, From 2020 to 2025 (USD Million)
  32. Italy Oxygen Therapy Market, By Application, From 2020 to 2025 (USD Million)
  33. Italy Oxygen Therapy Market, By End Use, From 2020 to 2025 (USD Million)
  34. Spain Oxygen Therapy Market, By Product, From 2020 to 2025 (USD Million)
  35. Spain Oxygen Therapy Market, By Application, From 2020 to 2025 (USD Million)
  36. Spain Oxygen Therapy Market, By End Use, From 2020 to 2025 (USD Million)
  37. Europe Blood Glucose Monitoring Market, By Type, From 2020 to 2025 (USD Million)
  38. Europe SMBG Market, By Region, From 2020 to 2025 (USD Million)
  39. Europe CGM Market, By Region, From 2020 to 2025 (USD Million)
  40. Europe 1 Market, By Region, From 2020 to 2025 (USD Million)
  41. Europe 2 Market, By Region, From 2020 to 2025 (USD Million)
  42. U.K. Blood Glucose Monitoring Market, By Type, From 2020 to 2025 (USD Million)
  43. Germany Blood Glucose Monitoring Market, By Type, From 2020 to 2025 (USD Million)
  44. France Blood Glucose Monitoring Market, By Type, From 2020 to 2025 (USD Million)
  45. Italy Blood Glucose Monitoring Market, By Type, From 2020 to 2025 (USD Million)
  46. Spain Blood Glucose Monitoring Market, By Type, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample